Asthma Drugs and the Risk of Congenital Anomalies

被引:23
|
作者
Vasilakis-Scaramozza, Catherine [1 ]
Aschengrau, Ann [1 ]
Cabral, Howard J. [1 ]
Jick, Susan S. [2 ]
机构
[1] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[2] Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA
来源
PHARMACOTHERAPY | 2013年 / 33卷 / 04期
关键词
asthma; congenital anomalies; prevalence rates; relative risk; MATERNAL ASTHMA; MEDICATION USE; PREGNANCY; CORTICOSTEROIDS;
D O I
10.1002/phar.1213
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective To estimate the prevalence of congenital anomalies between the offspring of women exposed and unexposed to asthma drugs during early pregnancy. Design Matched cohort study. Database The United Kingdom's General Practice Research Database. Patients Women exposed to asthma drugs during early pregnancy and a sample of matched unexposed pregnant women. Measurements and Main Results The prevalence of any anomaly among unexposed and exposed women was 27.8 (95% confidence interval [CI] 25.430.6)/1000 pregnancies and 31.3 (95% CI 27.735.5)/1000 pregnancies, respectively (relative risk [RR] 1.1 95% CI 1.01.3). Conclusion Our findings suggest that asthma drugs, overall, do not increase the risk of congenital anomalies in the offspring when taken during the first trimester of pregnancy.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 50 条
  • [21] Evaluation and Risk Assessment of Congenital Anomalies in Neonates
    Verma, Rita P.
    CHILDREN-BASEL, 2021, 8 (10):
  • [22] Exposure to air pollutants and risk of congenital anomalies: A systematic review and metaanalysis
    Ravindra, Khaiwal
    Chanana, Neha
    Mor, Suman
    SCIENCE OF THE TOTAL ENVIRONMENT, 2021, 765
  • [23] Effect of Maternal Asthma on the Risk of Specific Congenital Malformations: A Population-Based Cohort Study
    Blais, Lucie
    Kettani, Fatima-Zohra
    Elftouh, Naoual
    Forget, Amelie
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2010, 88 (04) : 216 - 222
  • [24] Pattern and risk factors of congenital anomalies in a pediatric university hospital, Alexandria, Egypt
    Abdou, Marwa Shawky Mohammed
    Sherif, Aida Ali Reda
    Wahdan, Iman Mohamed Helmy
    Ashour, Khaled Saad El Din
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, 2019, 94 (01): : 1 - 9
  • [25] Drugs for asthma
    Barnes, PJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 147 : S297 - S303
  • [26] Epidemiological Risk Factors and Perinatal Outcomes of Congenital Anomalies
    Garcia Almeida, Lissa Fernandes
    Araujo Junior, Edward
    Crott, Gerson Claudio
    Okido, Marcos Masaru
    Berezowski, Aderson Tadeu
    Duarte, Geraldo
    Marcolin, Alessandra Cristina
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2016, 38 (07): : 348 - 355
  • [27] Advanced Maternal Age and the Risk of Major Congenital Anomalies
    Goetzinger, Katherine R.
    Shanks, Anthony L.
    Odibo, Anthony O.
    Macones, George A.
    Cahill, Alison G.
    AMERICAN JOURNAL OF PERINATOLOGY, 2017, 34 (03) : 217 - 222
  • [28] Positive association between congenital anomalies and risk of neuroblastoma
    Menegaux, F
    Olshan, AF
    Reitnauer, PJ
    Blatt, J
    Cohn, SL
    PEDIATRIC BLOOD & CANCER, 2005, 45 (05) : 649 - 655
  • [29] Alcohol abuse - A persistent preventable risk for congenital anomalies
    Baumann, P.
    Schild, C.
    Hume, R. F.
    Sokol, R. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 (01) : 66 - 72
  • [30] Maternal Asthma, Asthma Medication Use, and the Risk of Congenital Heart Defects
    Lin, Shao
    Herdt-Losavio, Michele
    Gensburg, Lenore
    Marshall, Elizabeth
    Druschel, Charlotte
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2009, 85 (02) : 161 - 168